Effects of Reverse Natural Apophyseal Glides as Compared to Ventro-cranial Translatoric Glides in the Management of Upper Thoracic Spine Hypomobility.
Foundation University Islamabad
48 participants
Jul 18, 2024
INTERVENTIONAL
Conditions
Summary
This study is a randomized controlled trial and the purpose of the study is to determine the effects of reverse NAGs as compared to Ventro-cranial Translatoric Glides in upper thoracic spine hypomobility in terms of pain and range of motion.
Eligibility
Inclusion Criteria1
- \. Both male and females 2. Adults (18-39 years) 3. Upper Thoracic hypomobility (flexion <20° or extension <25° or side bending <20° or rotation <35°)
Exclusion Criteria1
- -Ankylosing spondylitis 2-History of Spinal Fusion or spinal surgery (discectomy/laminectomy etc.) 3-Degenerative disc disorders 4-Cervical radiculopathy, Scoliosis 5-Spinal Stenosis or Myelopathy 6-Recent fracture or surgery 7-TB of spine, Spondylolisthesis 8-Not able to attend regular therapy appointments 9-Fibromyalgia/myofascial pain syndrome
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
All participants will receive 2 weeks of intervention with a frequency of 3-4 days/week with a period of rest in between. 20 minutes of TENS+ hot pack will be given followed by Reverse NAGs on hypomobile segments at level T1-T4. In these type of mobilization, the inferior facet glides up on the superior. The mobilizations are repeated \<6 times and then movements are reassessed. If no change occurs, the process will be repeated upto 10 minutes with resting period.
All participants will receive 2 weeks of intervention with a frequency of 3-4 days/week with a period of rest in between. 20 minutes of TENS+ hot pack will be given followed by Grade III Ventro-Cranial Translatoric Glides on hypomobile segments at level T1-T4. The mobilization will be applied and sustained for 30-40 seconds and will be continued for 10-15 minutes in a cyclic manner. The grades of mobilization will be tapered as per individual needs.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07006402